Furthermore, a meta-analysis showed that high levels of REDD1 were associated with a worse prognosis in acute myeloid leukemia, breast cancer, glioblastoma, and colon and lung cancer but, in contrast, better prognosis in gastric cancer156. The gene discussed is DDIT4; the disease is breast cancer.